Literature DB >> 2159958

The serum rifabutin concentrations in a patient successfully treated for multi-resistant Mycobacterium tuberculosis infection.

S H Gillespie, A J Baskerville, R N Davidson, D Felmingham, A D Bryceson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2159958     DOI： 10.1093/jac/25.3.490

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

Review 1.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

2.  Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.

Authors:  Zenda L Berrada; Shou-Yean Grace Lin; Timothy C Rodwell; Duylinh Nguyen; Gisela F Schecter; Lucy Pham; J Michael Janda; Wael Elmaraachli; Antonino Catanzaro; Edward Desmond
Journal:  Diagn Microbiol Infect Dis       Date:  2016-02-03       Impact factor: 2.803

Review 3.  Clinical pharmacokinetics of rifabutin.

Authors:  M H Skinner; T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

4.  Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.

Authors:  W ElMaraachli; M Slater; Z L Berrada; S-Y G Lin; A Catanzaro; E Desmond; C Rodrigues; T C Victor; V Crudu; M T Gler; T C Rodwell
Journal:  Int J Tuberc Lung Dis       Date:  2015-10       Impact factor: 2.373
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.